Connect with us


Hexo, A Molson Coors CBD Beverages Partner, Closes Strong With $43.7 Million Deal



Molson Coors CBD Beverages Partner Closes Strong

Hexo Corp. is a licensed cannabis producer based in Quebec, Canada. Unlike in Canada, marijuana is illegal under federal law in the United States. By Wednesday of this past week, the company successfully raised nearly $60 million CAD, or $43 million USD. The company intends to use the proceeds for research, development, and global expansion.

The company’s shares Hexo, trade on the Toronto and the New York Stock exchanges. During trading, 8.8 million shares were available, each at $6.50 CAD. This last summer, the company also made an impressive decision, which was to partner with Molson Coors Canada. The partnership’s purpose is to produce CBD-infused beverages. The brewing company has a 57.5% interest in the venture.

At the time of the partnership, Molson Coors reported with it would be able to purchase a 5% stake in Hexo if the company’s stock reached $6 CAD a share. Clearly, the goal has been reached.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.